VIEWS ON THE NEWSIn this feature, we will highlight recent news or trends thatmight significantly impact your future as orthopaedic surgeons.We’ll print your views in subsequent issues.Below is a portion of a recent article describing something we are hearing more and moreabout. How will this be reconciled with the healthcare reforms currently under debate?As part of healthcare reform, different groups within the U.S. healthcare industry haveeither promised concessions to help reduce healthcare costs or are being targeted for feesthat will contribute to the financing of healthcare moving forward. For example,1) The hospital industry agreed to cut $155 billion in government costs overthe next ten years.2) The insurance industry agreed to remove preexisting condition limitationsfrom policies. Insurers would be assessed $6.7 billion in fees per yearfor ten years, based on their U.S. market shares.3) Pharmaceutical companies promised to spend more than $100 million toadvertise for reform and promised $80 billion in cost reductions over theten year period. In addition, as an industry they would be assessed a $2.3billion fee per year based on their market shares in the U.S.4) Medical device companies would pay $4 billion in fees per year based ontheir market shares in the U.S. (Those with sales below $5 million wouldpay nothing.)What do you think?Email your thoughts to usopn@orthoworld.com.46 ORTHOPAEDIC PRODUCT NEWS • November/December 2009
PRODUCT FEATURES<strong>Hip</strong> & <strong>Knee</strong> <strong>Surgery</strong>The Tradition <strong>Hip</strong> SystemThe BioPro® Tradition <strong>Hip</strong> carries on CharlesTownley, M.D.’s Horizontal PlatformSupport design philosophy.The implant is designedto be physiologicallystress loaded and incorporatesa platform perpendicularto theresultant forces ofbody weight and muscleforces. The design isintended to eliminateadaptive bone remodelingand stress shielding,which is a known causeof bone loss followingjoint replacement. Thetime tested designcomes in porous coatedand non-porouscoated versions in three differentlengths and thirteen sizes.The extra-short stem, or the Living<strong>Hip</strong>, is an ultra-short femoral stem availablein nine sizes with a minimal increase inlength, ranging from 95 mm to 115 mm in length. Due to the shortlength, the stem does not extend into or beyond the natural anteriorbow of the femur. This allows for increased proximal fill withresultant increased stability proximally.The ultra-short stem helps address the issue of thigh pain. Theelasticity of bone is greater than that of metal. If a stem extendsinto the anterior bow, the femur bends around the implant, causingirritation and pain. The Living <strong>Hip</strong> is proximal to the area ofthe bend, causing minimal irritation to the femur.BioProTel: 800-252-7707www.bioproimplants.com/hips.phpVascuTherm Iceless ColdTherapy, Compression and DVTProphylaxis TherapyThe VascuTherm by ThermoTek delivers a unique and proprietarythermal compression therapy solution in one easily transportabledevice. Its solid-state technology eliminates the need forice, offers precise temperature control for preventing thermal tissuedamage, and delivers exceptional reliability. VascuThermoffers highly effective DVT prophylaxis through its programmablemultiple treatment modalities, combining heating/coolingtemperature management with vascular compression and isMedicare HCPCS listed.Treatment Modalities: Compression Therapy • DVT Prophylaxis• Cold Therapy • Heat Therapy • Contrast TherapyIndications: Edema • Lymphedema • Arterial Insufficiency •PainThermoTek, Inc.Tel: 972-874-4949www.thermotekusa.comAlternative Surface Technology for <strong>Knee</strong> ImplantsAesculap Implant Systems markets Alternative Surface (AS) Technology, an advanced coating system forknee implants that offers a surface with advantages over Cobalt Chrome (CoCr). The coating, whichreportedly produces less wear and releases significantly fewer metal ions than CoCr, will be applied toAesculap's Columbus knee.The seven-layer coating is composed primarily of Zirconium Nitride, a durable ceramic material thatcreates a harder and more durable surface than traditional implant materials. In ISO wear testing, the surfacehas shown wear rates of just 3.5 mg/million cycles. ISO-certified laboratory testing also indicated thatthe release of Ni ions has been significantly reduced. Additionally, the design of the seven-layer coatingaids in the prevention of mechanical ablation, a separation of the coating from the substrate, which may bea shortcoming of some mono-layer coatings.The Columbus knee system features a full portfolio of AS-coated components, including Femur and Tibiacomponents as well as Tibial Augments and Stems.Aesculap Implant Systems, Inc.Tel: 866-229-3002www.aesculapimplantsystems.comNovember/December 2009 • ORTHOPAEDIC PRODUCT NEWS 47